Omari AA, Al-Ashqar R, Nuseir A, AL Balas H, Allan H, Kanaan Y, Alzoubi F. Overview of Upper Airway Management During COVID-19 Outbreak: Head and Neck Surgeon's Perspective.
J Craniofac Surg 2020;
31:e644-e649. [PMID:
32649566 PMCID:
PMC7382411 DOI:
10.1097/scs.0000000000006798]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2020] [Accepted: 05/27/2020] [Indexed: 01/08/2023] Open
Abstract
At the end of December, 2019, a new virus was named severe acute respiratory syndrome coronavirus 2 appeared in Wuhan, China, and the disease caused is called as coronavirus disease 2019 (COVID-19) by World Health Organization, which to date having infected more than 3,588,773 people worldwide, as well as causing 247,503 deaths. A human to human transmission is thought to be predominantly by droplet spread, and direct contact with the patient or contaminated surfaces. This study aims to provide a comprehensive overview as well as to highlight essential evidence-based guidelines for how head and neck surgeon and healthcare providers need to take into consideration during their management of the upper airway during the COVID-19 pandemic safely and effectively to avoid the spread of the virus to the health provider.
Collapse